Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bendamustine Plus Rituximab Versus CHOP Plus Rituximab

This study has been completed.
Information provided by (Responsible Party):
Jurgen Barth, University of Giessen Identifier:
First received: October 6, 2009
Last updated: March 13, 2012
Last verified: October 2009